HomeMedicine
Medicine
Align ENT + Allergy Expands into Michigan
EAST LANSING, Mich., Sept. 19, 2024 /PRNewswire/ -- Align ENT + Allergy ("Align") is excited to announce its partnership with Mid-Michigan ENT, a leading private practice in East Lansing, Michigan. This significant move marks Align's expansion into Michigan and its fourth state, strengthening its...
Cancer Research Sees Major Boost as New Breakthroughs Emerge from Key Oncology Players
USA News Group CommentaryIssued on behalf of Oncolytics Biotech Inc.
VANCOUVER, BC, Sept. 19, 2024 /PRNewswire/ -- USA News Group – In the oncology world, there's been plenty to celebrate recently, with cancer deaths falling by 33% in the last 30 years. However, there's still a lot...
HandicapMD.com Expands Its Leading Telemedicine Service for Disabled Parking Placards in California
HandicapMD's video telehealth platform connects California state-licensed physicians to patients, offering quick, secure, and affordable online evaluations for disabled parking placards.
LOS ANGELES, Sept. 19, 2024 /PRNewswire/ -- HandicapMD, the nation's leading telemedicine platform for disabled parking permits, is expanding its services across California. Since...
Flashpoint Therapeutics Scientific Founder, Chad Mirkin, Receives 2024 Kavli Prize for Groundbreaking Work on Spherical Nucleic Acids
Award Marks Milestone in Flashpoint's Journey to Translate Cutting Edge Science into Breakthrough Therapies
CHICAGO, Sept. 19, 2024 /PRNewswire/ -- Flashpoint Therapeutics proudly announces that its scientific founder, Professor Chad A. Mirkin, has been awarded the 2024 Kavli Prize in Nanoscience for his pioneering work on...
Advancing Pediatric Care Through Technology: Office Practicum Launches New Patient Portal Powered by BridgeInteract
FORT WASHINGTON, Pa., Sept. 19, 2024 /PRNewswire/ -- Office Practicum, a leading provider of pediatric-focused Electronic Health Record (EHR) and practice management solutions, today announced the launch of its new Patient Portal, powered by BridgeInteract, a pioneer in patient engagement platforms. This collaboration brings together...
Abbott Declares 403rd Consecutive Quarterly Dividend
ABBOTT PARK, Ill., Sept. 19, 2024 /PRNewswire/ -- The board of directors of Abbott (NYSE: ABT) today declared a quarterly common dividend of 55 cents per share.
This marks the 403rd consecutive quarterly dividend to be paid by Abbott since 1924. The cash dividend is...